Cite
HARVARD Citation
Ebert, E. et al. (2020). Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epidermal growth factor receptor mutated non-small cell lung cancer. Lung cancer. pp. 37-43. [Online].